Maxcyte Inc (MXCT)

EBITDA Margin

-105.47%

Quarterly · Period ending:

MXCT logo

MXCT EBITDA Margin

Latest reported-105.47%
MXCT Quarterly EBITDA Margin (-29.61% → -105.47%)
High-resolution chart · PNG

MXCT ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maxcyte Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-105.4738%
-38.3691%
-113.8219%
-163.0546%
-130.0106%
-86.4678%
-109.7435%
-128.5032%
-79.5282%
-74.1933%
-26.6588%
-160.8071%
-104.8988%
-115.6716%
-31.222%
-53.4671%
-80.2744%
-30.895%
-43.9115%
-19.9761%
-57.4429%
-93.11%
-24.5701%
-37.6364%
-50.1495%
-48.1818%
-23.434%
-23.434%
-103.9268%
-103.9268%
-38.631%
-38.631%
-62.329%
-62.329%
-67.1378%
-67.1378%
-63.2663%
-63.2663%
-25.1841%
-25.1841%
-16.5459%
-16.5459%
-2.4582%
-2.4582%
-12.928%
-12.928%
-7.3081%
-7.3081%
-29.6131%
-29.6131%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.